Day 1 – 7 July 2014

• The big picture: global value chain for TB diagnostics (by M Pai) [Slides] [Video]
• Panel discussion: Scale-up of existing WHO-endorsed tools – country experiences and challenges [Video]
• Panel discussion: Private sector: how do we scale-up WHO-endorsed tests? [Video]
• Beyond Xpert: fast-followers and NAAT pipeline (by D Boyle) [Slides]
• Panel discussion: Gaps in the pipeline: priority target product profiles [Video]
• Panel discussion: Can industry fill the gaps? [Video]

Day 2 – 8 July 2014

• Panel discussion: What is the market for TB diagnostics? [Not available]
• Panel discussion: Optimal reference standards for test evaluation [Video]
• Diagnostic prediction models and incremental value (by S Schumacher) [Slides]
• Impact of test results on diagnostic thinking (by M Pai) [Slides]
• Diagnostic RCTs in TB: Same-day smear diagnosis (by A Ramsay) [Slides]
• Diagnostic RCTs in TB: Xpert MTB/RIF (by G Theron) [Slides]
• TB tech pitch [Not available]

Day 3 – 9 July 2014

• Panel discussion: Measuring clinical impact: methodological issues and challenges [Slides] [Video]
• Implementation research in TB diagnostics: case studies (by A Cattamanchi) [Slides]
• Implementation research in TB diagnostics: case studies (by A Ramsay) [Slides]
• Barriers to POC testing: insights from qualitative research (by N Engel) [Slides]
• Xpert MTB/RIF in high incidence settings: TB REACH experience (by J Creswell) [Slides]
• Importance of reproducibility: case study of IGRAs (by N Banaei) [Slides]
• Panel discussion: Are high burden countries ready for molecular tests? [Slides] [Video]

Day 4 – 10 July 2014

• Systematic reviews of diagnostic accuracy (by K Steingart) [Slides]
• SR: case study: Xpert for EPTB (by S Schumacher) [Slides]
• SR: case study: Predictive value of IGRAs and TST (by S Kik) [Not available]
• Guideline development in TB diagnostics (by K Steingart) [Slides]
• Panel discussion: How do countries make policies on new diagnostics? [Video]
• Mathematical modeling: an introduction (by D Dowdy) [Slides]

Day 5 – 11 July 2014

• Transmission modeling of TB diagnostics (by D Dowdy) [Slides]
• Cost-effectiveness analysis of TB diagnostics (by D Dowdy) [Slides]
• Challenges in modeling TB diagnostics (by D Dowdy) [Slides]
• Modeling for decision-making (by D Dowdy) [Slides]
• Panel discussion: Linking models to decision-making in public health & policy [Video]
• Modeling and cost-effectiveness: a synthesis (by D Dowdy) [Slides]